Presentation TCT 2013 The Inventive Process: From Concept to Clinical Execution Presenter: Alain Cribier October 27, 2013
Presentation TCT 2013 Strengthening Our National System for Medical Device Postmarket Surveillance Presenter: John Laschinger October 27, 2013
Presentation TCT 2013 Status Update on the Randomized Moderate Risk AS Trials: SURTAVI Presenter: Patrick Serruys October 27, 2013
Presentation TCT 2013 Status Update on the Randomized Moderate Risk AS Trials: PARTNER 2A Presenter: Martin Leon October 27, 2013
Presentation TCT 2013 PMS in the Japan-US HBD: Past, Present, and Future - PMDA Presenter: Nobuhiro Handa October 27, 2013
Presentation TCT 2013 PARTNER A (Surgery vs. TAVR at 2 Years): Essential Results Presenter: Martin Leon October 27, 2013
Presentation TCT 2013 Palliative at Best: A Bridge to Other Definitive Therapies Presenter: Martyn Thomas October 27, 2013
Presentation TCT 2013 NO – Surgery is Clearly the Gold Standard Presenter: Lars Svensson October 27, 2013
Presentation TCT 2013 My Crystal Ball: The Future of Surgical AVR in the Era of TAVR Presenter: Craig Smith October 27, 2013
Presentation TCT 2013 My Crystal Ball: How Will the Aortic Stenosis Guidelines Change in the Next Decade with the Integration of TAVR? Presenter: Robert Bonow October 27, 2013
Presentation TCT 2013 Meaningful Tool with Potential Long-term Benefits Presenter: David Brown October 27, 2013
Presentation TCT 2013 Japanese TVT Registry: Cardiologist's View Presenter: Shigeru Saito October 27, 2013
Presentation TCT 2013 Is Aortic Stenosis Undertreated in the Real World? Epidemiologic, Socioeconomic, and Disease Awareness Issues Presenter: Patrick O'Gara October 27, 2013
Presentation TCT 2013 Insights on Frailty from the U.S. CoreValve Extreme Risk Registry Presenter: Jeffrey Popma October 27, 2013
Presentation TCT 2013 Insights from the Worldwide Valve-in-Valve TAVR Registry Presenter: Danny Dvir October 27, 2013